97302 ⎘
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen Internalization into the cell
Method and Constructs for the pH Dependent Passage of the Blood-brain-barrier
#1502Synergistic anti-CD47 therapy for hematologic cancers
#1503PHARMACEUTICAL COMPOSITION COMPRISING ANTI-HB-EGF ANTIBODY AS ACTIVE INGREDIENT
#1504Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity
#1505Binding molecules for the treatment of myeloid cell malignancies
#1506Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent
#1507c-Met antibodies
#1508Targeted carriers for drug delivery across the gastrointestinal epithelium
#1509Pro104 Antibody Compositions and Methods of Use
#1510METHOD OF DELIVERING RNA INTERFERENCE AND USES THEREOF
#1511Generation of anti-FN14 monoclonal antibodies by ex-vivo accelerated antibody evolution
#1512Anti-fibroblast activation protein antibodies and methods and uses thereof
#1513Antibodies that bind TGF-alpha and epiregulin
#1514Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibodies
#1515COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY
#1516Optimized Fc Variants
#1517STEM CELL TARGETING
#1518STABILIZED SINGLE DOMAIN ANTIBODIES
#1519COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY
#1520COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY
#1521ANTI-ALPHA V BETA 6 ANTIBODIES
#1522Human monoclonal antibodies against CD25
#1523Multivalent antibodies and uses therefor
#1524Anti-mesothelin antibodies
#1525Monovalent Antigen Binding Proteins
#1526Dual FC antigen binding proteins
#1527Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen as diagnostic and therapeutic tools for prostate cancer
#1528ANTIBODIES
#1529Optimized Fc variants and methods for their generation
#1530Immuno-based botulinum toxin serotype A activity assays
#1531Immunoglobulin insertions, deletions, and substitutions
#1532Anti-mesothelin antibodies and immunoconjugates
#1533Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment
#1534Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7)
#1535Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use
#1536Methods and compositions for treatment of myotubular myopathy using chimeric polypeptides comprising myotubularin 1(MTM1) polypeptides
#1537Treating lung cancer using human monoclonal antibodies to protein tyrosine kinase 7 (PTK7)
#1538GENERATION, CHARACTERIZATION AND USES THEREOF OF ANTI-HER3 ANTIBODIES
#1539ANTI-KIT ANTIBODIES AND USES THEREOF
#1540TREATMENT OF COMPLEMENT-ASSOCIATED DISORDERS
#1541Fully human antibodies to BTLA
#1542Specific binding proteins and uses thereof
#1543In vivo polynucleotide delivery conjugates having enzyme sensitive linkages
#1544Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells
#1545Methods of treating hemophilia using monoclonal antibodies against activated protein C
#1546ANTI-FOLATE RECEPTOR ALPHA ANTIBODY GLYCOFORMS
#1547Compositions and methods comprising phosphatidylethanolamine-binding peptide derivatives
#1548Methods and compositions for inhibiting CD32B expressing cells
#1549Methods and compositions for inhibiting CD32B expressing cells
#1550Monoclonal antibodies to dendritic cells
#1551Methods and compositions for inhibiting CD32b expressing cells
#1552METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE-CHALLENGED ANIMALS
#1553Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
#1554Human binding molecules having killing activity against staphylococci and uses thereof
#1555Targeted therapeutic proteins
#1556TRANS-MEMBRANE-ANTIBODY INDUCED INHIBITION OF APOPTOSIS
#1557Anti-ILT7 antibody
#1558Anti-Met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products
#1559POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCES INVOLVED IN CANCER
#1560Immuno-based botulinum toxin serotype A activity assays
#1561Humanized AXL antibodies
#1562Composition of anti-ENDO180 antibodies and methods of use for the treatment of cancer and fibrotic diseases
#1563Antibodies specific to cadherin-17
#1564Ang-2 Binding Complexes and Uses Thereof
#1565Antibodies or fragments thereof directed against a epitope of ISAA or ISAB
#1566Anti-ferroportin 1 monoclonal antibodies and uses thereof
#1567Fully human antibodies specific to CADM1
#1568LOX AND LOXL2 INHIBITORS AND USES THEREOF
#1569CD33 binding agents
#1570OPTIMIZED ANTIBODIES THAT TARGET CD19
#1571Peptides for transport of therapeutics and their carriers in mouse models and humans
#1572Amino acid sequences which enhance peptide conjugate solubility
#1573IMMUNOTHERAPY REGIMES DEPENDENT ON APOE STATUS
#1574Anti-5T4 antibodies and uses thereof
#1575SUPERANTIBODY SYNTHESIS AND USE IN DETECTION, PREVENTION AND TREATMENT OF DISEASE
#1576Methods For Treating Diseases and HCV Using Antibodies To Aminophospholipids
#1577PSCA: prostate stem cell antigen and uses thereof
#1578Antibodies directed to HER-3 and uses thereof
#1579THERAPEUTIC APPLICATIONS OF NONCOVALENT DIMERIZING ANTIBODIES
#1580Human monoclonal antibodies to activin receptor-like kinase-1
#1581Glioblastoma multiforme-reactive antibodies and methods of use thereof
#1582Antibodies for depletion of ICOS-positive cells in vivo
#1583Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cells
#1584TLR3 binding agents
#1585METHODS OF IMPROVING THE THERAPEUTIC EFFICACY AND UTILITY OF ANTIBODY FRAGMENTS
#1586HB-EGF BOUND PROTEIN COMPLEX
#1587Anti-RON antibodies
#1588Photosensitizing antibody-fluorophore conjugates
#1589Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment
#1590Diagnosis and treatment of cancer using anti-TM4SF20 antibody
#1591COMPOSITIONS AND METHODS OF USE OF TARGETING PEPTIDES FOR DIAGNOSIS AND THERAPY OF HUMAN CANCER
#1592NOVEL METHODS OF CANCER DIAGNOSIS AND THERAPY TARGETED AGAINST A CANCER STEM LINE
#1593DEGLYCOSYLATED ANTIBODIES
#1594SPECIFIC BINDING PROTEINS AND USES THEREOF
#1595CD19 binding agents and uses thereof
#1596Inhibitors of receptor tyrosine kinases and methods of use thereof
#1597Platelet derived growth factor receptor supports cytomegalovirus infectivity
#1598Prevention and Treatment of Amyloidogenic Disease
#1599Camptothecin conjugates of anti-CD22 antibodies for treatment of B cell diseases
#1600Anti-αβantibodies and uses thereof
#1601Anti-human CLCP1 antibody and use thereof
#1602ISOFORM SPECIFIC ANTI-HER4 ANTIBODIES
#1603SPECIFIC BINDING PROTEINS AND USES THEREOF
#1604PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES
#1605Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
#1606TOXIN CONJUGATED EPH RECEPTOR ANTIBODIES
#1607NOVEL ANTI-HSP90 MONOCLONAL ANTIBODY
#1608Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity
#1609Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conjugates
#1610J591 minibodies and Cys-diabodies for targeting human prostate specific membrane antigen (PSMA) and methods for their use
#1611CELL-PENETRATING, SEQUENCE-SPECIFIC AND NUCLEIC ACID-HYDROLYZING ANTIBODY, METHOD FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
#1612BLOOD-BRAIN BARRIER TARGETING ANTIBODIES
#1613Human antibodies that bind mesothelin, and uses thereof
#1614METHODS OF TREATING INFLAMMATION
#1615Internalizing Anti-CD74 Antibodies and Methods of Use
#1616ISOLATED MAMMALIAN MEMBRANE PROTEIN GENES; RELATED REAGENTS
#1617Antibodies to LRP6
#1618Antibodies against CSF-1R
#1619Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells
#1620Method of inhibiting infection by HCV, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood by preventing viral entry into a cell
#1621Methods using recombinant anti-epidermal growth factor receptor antibody compositions
#1622Humanized C-kit antibody
#1623Internalizing ErbB2 antibodies
#1624TREATMENT OF THROMBOCYTOPENIA
#1625Targeting poly-γ-glutamic acid to treat and related infections
#1626Nucleic acids encoding monoclonal antibodies to programmed death ligand 1 (PD-L1)
#1627SAM-6 VARIANTS, TARGET AND METHODS OF USE
#1628Compositions and methods for the diagnosis and treatment of tumor
#1629COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN
#1630Antibodies binding to an intracellular PRL-1 or PRL-3 polypeptide
#1631Internalizing Anti-CD74 Antibodies and Methods of Use
#1632PROSTATE SPECIFIC MEMBRANE ANTIGEN ANTIBODIES AND ANTIGEN BINDING FRAGMENTS
#1633Dock-and-lock (DNL) vaccines for cancer therapy
#1634SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREFOR
#1635METHOD OF ADMINISTERING THERAPEUTIC POLYPEPTIDES, AND POLYPEPTIDES THEREFOR
#1636METHODS OF IDENTIFYING COMBINATIONS OF ANTIBODIES WITH AN IMPROVED ANTI-TUMOR ACTIVITY AND COMPOSITIONS AND METHODS USING THE ANTIBODIES
#1637PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES
#1638HUMANIZED ANTI-CD22 ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE
#1639STABILIZED SINGLE DOMAIN ANTIBODIES
#1640Inhibition of Tumor Angiogenesis by Inhibition of Peroxiredoxin 1 (PRX1)
#1641COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF OVARIAN CANCER
#1642Compositions and methods for inhibiting PDGFRβ and VEGF-A
#1643PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES
#1644Modulation of the Vps10p-domain for the treatment of cardiovascular disease
#1645NK-1 Receptor Mediated Delivery of Agents to Cells
#1646Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
#1647ANTI-NUCLEIC ACID ANTIBODY INDUCING CELL DEATH OF CANCER CELLS AND COMPOSITION FOR PREVENTING OR TREATING CANCERS COMPRISING THE SAME
#1648EBI3, DLX5, NPTX1 AND CDKN3 FOR TARGET GENES OF LUNG CANCER THERAPY AND DIAGNOSIS
#1649Anti-hepcidin antibodies and methods of use
#1650EPHRIN-B RECEPTOR PROTEIN INVOLVED IN CARCINOMA
#1651Antibodies and immunoconjugates and uses therefor
#1652Humanized antibodies that recognize beta amyloid peptide
#1653Method And Composition For The Treatment Of Cancer By The Enzymatic Conversion Of Soluble Radioactive Toxic Precipitates In The Cancer
#1654Compositions and methods for the diagnosis and treatment of tumor
#1655ANTI-FERROPORTIN 1 MONOCLONAL ANTIBODIES AND USES THEREOF
#1656SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREFOR
#1657Dock-and-lock (DNL) complexes for delivery of interference RNA
#1658PCSK9 inhibitors and methods of use thereof
#1659Monoclonal antibody specific to anthrax toxin
#1660ANTIGEN-BINDING MOLECULE CAPABLE OF BINDING TO TWO OR MORE ANTIGEN MOLECULES REPEATEDLY
#1661Anti-GCC antibody molecules and related compositions and methods
#1662Multivalent Antibodies and Uses Therefor
#1663Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous system
#1664Methods and Compositions for Diagnosing Carcinomas
#1665Anti-CD19 antibodies and uses in B cell disorders
#1666Siglec-9 Binding Agents
#1667METHOD FOR THE TREATMENT OR PROPHYLAXIS OF CHRONIC INFLAMMATORY DISEASES
#1668Blockage of interferon-gamma for prevention of polymicrobial synergy
#1669HUMAN IgM ANTIBODIES, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF PARTICULARLY IN THE CENTRAL NERVOUS SYSTEM
#1670Antibodies against CD38 for treatment of multiple myeloma
#1671Process for producing hepcidin
#1672BLOOD-BRAIN BARRIER EPITOPES AND USES THEREOF
#1673NOVEL DOSING REGIMEN AND METHOD OF TREATMENT
#1674Composition and Method of Use for HCV Immunization
#1675MODULATION OF CELL JUNCTIONS
#1676ANTI-FLT3 ANTIBODIES
#1677Method for administering homeopathically potentiated antibodies against mediator of inflammation
#1678SPECIFIC BINDING PROTEINS AND USES THEREOF
#1679Immunizing composition and method for inducing an immune response against the β-secretase cleavage site of amyloid precursor protein
#1680COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC
#1681Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy
#1682PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#1683ANTI-ROBO4 ANTIBODIES AND USES THEREFOR
#1684MAMMALIAN RECEPTORS AS TARGETS FOR ANTIBODY AND ACTIVE VACCINATION THERAPY AGAINST MOLD INFECTIONS
#1685ANTI-ROBO4 ANTIBODIES AND USES THEREFOR
#1686Rationally-designed anti-αβν6 integrin antibody MFEVP1 and variants thereof, method of making such antibody and the use thereof in treating and diagnosis of disease
#1687FUSION OR LINKED PROTEINS WITH EXTENDED HALF LIFE
#1688LUCA2 and Antibodies That Bind Thereto
#1689COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN
#1690METHODS OF TREATMENT USING ANTI-MIF ANTIBODIES
#1691Anti-amyloid antibodies and uses thereof
#1692COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN
#1693Compositions and methods to enhance the immune system
#1694Antibodies against cancer antigen TMEFF2 and uses thereof
#1695Methods For Treating Diseases Using Antibodies to Aminophospolipids
#1696Cysteine Engineered Antibodies For Site-Specific Conjugation
#1697Monoclonal antibodies against prostate specific membrane antigen (PSMA) lacking in fucosyl residues
#1698Anti-mesothelin antibodies and uses thereof
#1699Optimized Fc Variants
#1700Bispecific Immunocytokine Dock-and-Lock (DNL) Complexes and Therapeutic Use Thereof
#1701Anti-FLT3 antibodies
#1702Methods of Treating RSV Infections And Related Conditions
#1703NLRR-1 antagonists and uses thereof
#1704NON-GLYCOSYLATED RECOMBINANT MONOVALENT ANTIBODIES
#1705Antibodies against a cancer-associated epitope of variant NFKBIB and uses thereof
#1706KID3 and KID3 antibodies that bind thereto
#1707PAPAYA MOSAIC VIRUS-BASED VACCINES AGAINST SALMONELLA TYPHI AND OTHER ENTEROBACTERIAL PATHOGENS
#1708Liposomes comprising duramycin and anti-viral agents
#1709Antigen
#1710Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
#1711Recombinant IgG4 monovalent antibodies
#1712Human monoclonal antibodies to epidermal growth factor receptor
#1713COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF TUMOR
#1714Antibodies against a cancer-associated epitope of variant HnRNPG and uses thereof
#1715Antibodies directed to mGluR7
#1716Paratope and epitope of anti-mortalin antibody
#1717Human monoclonal antibodies to fucosyl-GM1 and methods for using anti-fucosyl-GM1
#1718Anti-CD40 targeted fusion proteins
#1719Crystal structures and methods using same
#1720ANTIBODIES TO IREM-1
#1721Fusion protein with HIV antigen
#1722Anti-MRP3 antibodies and methods of use
#1723Antibodies to CLL-1
#1724Internalizing Anti-CD74 Antibodies and Methods of Use
#1725ANTI-EPHB2 ANTIBODIES AND METHODS USING SAME
#1726Prevention and treatment of synucleinopathic and amyloidogenic disease
#1727Alpha-emitting constructs and uses thereof
#1728Optimized antibodies that target CD19
#1729THERAPEUTIC ANTENNAPEDIA-ANTIBODY MOLECULES AND METHODS OF USE THEREOF
#1730Immunotherapy regimes dependent on ApoE status
#1731Internalizing anti-CD74 antibodies and methods of use
#1732Bispecific Anti ErbB3 / Anti cMet Antibodies
#1733Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
#1734RECOMBINANT FUCOSE MODIFIED MONOVALENT HALF-ANTIBODIES OBTAINED BY MOLECULAR ENGINEERING
#1735Bispecific Anti ErbB1 / Anti c Met Antibodies
#1736Bispecific Anti ErbB2 / Anti cMet Antibodies
#1737Engineered proteins with high affinity for DOTA chelates
#1738Modified FC molecules
#1739OPSONIC MONOCLONAL AND CHIMERIC ANTIBODIES SPECIFIC FOR LIPOTEICHOIC ACID OF GRAM POSITIVE BACTERIA
#1740Anti-FGFR3 antibodies and methods using same
#1741Method of treating disorders of the cardiovascular system and a pharmaceutical agent
#1742Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
#1743Method for preparation of single chain antibodies
#1744Polynucleotides encoding humanized and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
#1745Method of treating a pathological syndrome and a pharmaceutical agent
#1746Immunotoxin Fusions Comprising An Antibody Fragment and a Plant Toxin Linked by Protease Cleavable Linkers
#1747Humanized antibodies that bind to CD19 and their uses
#1748OVR110 Antibody Compositions and Methods of Use
#1749Monoclonal antibodies against glypican-3
#1750Blood-brain barrier targeting anti-bodies
#1751Immuno-based botulinum toxin serotype A activity assays
#1752Method of treating a disorder or condition of viral etiology
#1753Method of providing disease-specific binding molecules and targets
#1754Human monoclonal antibodies to activin receptor-like kinase-1
#1755ANTIBODY CONJUGATES FOR CIRCUMVENTING MULTI-DRUG RESISTANCE
#1756Method of determining immune enhancement of virus infectivity using Fc receptor-transfected cell lines
#1757Strategies for improved cancer vaccines
#1758Binding molecules for the treatment of myeloid cell malignancies
#1759Antibodies directed to HER-3 and uses thereof
#1760TES7 and antibodies that bind thereto
#1761Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
#1762ANTIGEN-BINDING PROTEINS TARGETING S. AUREUS ORF0657n
#1763Method for administering homeopathically potentized antibody
#1764Transferrin receptor antibodies
#1765Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
#1766ANTIBODIES, METHODS AND KITS FOR DIAGNOSING AND TREATING MELANOMA
#1767Fully human antibodies directed against the human insulin-like growth factor-1 receptor
#1768ANTI-CD19 ANTIBODY THERAPY FOR AUTOIMMUNE DISEASE
#1769HUMAN ANTIBODIES THAT BIND CD70 AND USES THEREOF
#1770Human antibodies that bind CD22 and uses thereof
#1771LINGO binding molecules and pharmaceutical use thereof
#1772Use of Antibody Conjugates
#1773Monoclonal antibodies to human thymidine kinase to treat cancer
#1774OVR110 antibody compositions and methods of use
#1775c-Met antibodies
#1776TREATMENT OF PSORIATIC ARTHRITIS WITH ANTI-CD70 ANTIBODY
#1777Anti-MN antibodies and methods of using same
#1778Compositions and Methods for Treating Pancreatic Tumors
#1779DLL4 Signaling Inhibitors and Uses Thereof
#1780Light targeting molecules and uses thereof
#1781Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
#1782ADAM-9 modulators
#1783HUMAN ANTIBODIES THAT BIND CD19 AND USES THEREOF
#1784Anti-IGF-1R Antibodies and Uses Thereof
#1785ANTIBODIES AGAINST A PROTEIN ENTITLED 161P2F10B
#1786Fusion Proteins Comprising Two or More IgG Binding Domains of Streptococcal Protein G
#1787Anti-IGR-1R antibodies and uses thereof
#1788Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)
#1789Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment
#1790Anti-EpCAM antibody and uses thereof
#1791Antibodies that bind to EphA2 and methods of use thereof
#1792Immunoliposomes that optimize internationalization into target cells
#1793Dock-and-lock (DNL) vaccines for cancer therapy
#1794Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic precipitates in the cancer
#1795Antibodies for selective apoptosis of cells
#1796Rhamm, a Co-Receptor and Its Interactions with Other Receptors in Cancer Cell Motility and the Identification of Cancer Prognitor Cell Populations
#1797PHARMACEUTICAL COMPOSITION COMPRISING ANTI-HB-EGF ANTIBODY AS ACTIVE INGREDIENT
#1798SPECIFIC BINDING PROTEINS AND USES THEREOF
#1799INHIBITION OF FcyR-MEDIATED PHAGOCYTOSIS WITH REDUCED IMMUNOGLOBULIN PREPARATIONS
#1800ANTI HER2/NEU ANTIBODY